We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Vaccine Candidate is the most clinically advanced of a new generation of vaccines under development to combat the TB epidemic.
Two Oxford spin-out companies have been honoured at the inaugural BBSRC Innovator of the Year awards, organised by the Biotechnology and Biological Sciences Research Council (BBSRC). The awards recognise UK bioscientists who have been best at turning world-class research into a product, company, service or advice to have an impact on our lives.
Start-up and spin-out companies are often on the look out for suitably qualified candidates to take on management roles.
The Prime Minister, The Rt Hon Gordon Brown MP, visited the University of Oxford on 27th February to deliver the Romanes lecture on ‘Science and our Economic Future’.
Lord Paul Drayson visited Oxford University Innovation on January 23rd 2009.
Oxford University Innovation is recognised as a key player in supporting technology business in the region, in a new report published today by James Cowper and Peters Elworthy & Moore.
Some observations...
Isis is committed to transferring technology to the best customer companies regardless of geographic boundaries and time differences.
Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, has acquired Isis spin-out BioAnaLab.
A novel structural basis for class III anti-arrhythmia therapeutic molecules has been identified by research within Oxford University's Department of Pharmacology.
